Home Asbestos Bad Drugs Lead Paint Silica Mercury Toxic Mold

Heparin Lawsuits

| Digitek | Heparin | Avandia | Chantix | Fosamax | Vioxx | Celebrex | Statin Drugs | Bad Supplements | Diet Drugs | Antidepressants | Bextra | Lamictal | Ketek | Trayslol | Fentanyl |

The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.

Serious reactions to the drug have included difficulty breathing, nausea, vomiting, excessive sweating, and rapidly falling blood pressure that can lead to life-threatening shock. Four people have died after receiving heparin, although the relationship to the drug is unclear.

Heparin sodium is derived from pig intestines and has been marketed in the United States since the 1930s. Millions of patients benefit from the intravenous administration of this drug every year to avoid potentially life-threatening blood clots in the veins, arteries, and lungs.

"FDA concurs with Baxter's decision to halt manufacture of heparin sodium in multiple-dose vials," said Janet Woodcock, M.D., FDA's deputy commissioner for scientific and medical programs, chief medical officer, and acting director of its Center for Drug Evaluation and Research. "FDA is vigorously investigating to determine the root cause of these serious reactions associated with the use of heparin made by Baxter. In the meantime, patients and health care professionals who cannot obtain alternative sources of heparin should use caution in administering any Baxter multiple-dose vials that remain."

Heparin is commonly used before certain types of surgery, including coronary artery bypass graft surgery, and in kidney patients before they undergo dialysis. In some situations, heparin treatment is initiated using a high bolus dose given directly into the bloodstream (intravenously) over a short period of time, usually less than one hour. The reported adverse events occurred in patients who were given heparin in this form of administration. There are many other uses of heparin involving lower doses or administration over a longer period of time; adverse events have not been seen with those uses.

About 350 adverse events associated with the Baxter product have been reported since the end of last year compared to less than 100 reports in 2007. Most of the events have taken place at hemodialysis centers, almost exclusively involving patients receiving a bolus dose which is a high dose administered over a short time. While most of the reports involve multiple-dose vials, several cases include patients who received a bolus dose after their health care professional combined heparin from single-dose vials.

The Missouri Department of Health and Senior Services first notified the Centers for Disease Control and Prevention (CDC) in January of several severe allergic-type reactions to heparin that occurred at a single pediatric hospital beginning in November. The CDC in turn alerted FDA and Baxter, prompting the company's voluntary recall of nine lots of heparin on Jan. 17.

Since then, FDA has learned of adverse events that extend beyond the recalled lots and involve patients receiving heparin for other purposes besides hemodialysis. Recent cases have included patients undergoing cardiac surgery and a specialized blood cell treatment known as photopheresis.

Over one million multiple-dose vials of heparin are sold per month in the United States; half of the vials are manufactured by Baxter of Deerfield, Ill. FDA is currently investigating whether similar events have been seen with other heparin manufacturers.

If you have questions about contaminated Heparin, please feel free to e-mail your questions about the blood-thinning drug.

The ToxicDoseLaw.com Website was developed by Texas Dangerous Drug Attorney Jason Coomer.  He is a Texas Heparin Lawyer who commonly works with other lawyers throughout the nation including Chicago Heparin Lawyers, Boston Heparin Lawyers, New York Heparin Attorneys, California Heparin Attorneys, Houston Heparin Lawyers, Oklahoma Pharmaceutical Lawyers, Dallas Defective Medication Lawyers, and other Texas Dangerous Drug Claim Lawyers.  By sharing information and working together, his law firm and other firms throughout the nation are able to provide better representation for there clients.  For more information on Texas Lawyer Jason Coomer, go to his Law Firm's Web Site.


The ToxicDoseLaw.com and ToxicExposureLaw.com websites provide information on dangerous medications, bad drugs, dangerous products, toxic substances, and defective products that can cause serious toxic exposures, toxic deaths, serious diseases including mesothelioma & cancer, or toxic exposures.

It is well established that many large corporations have profited from selling toxic products or products that cause toxic exposure without regard to the health consequences of the products.  Some of the most well known toxic products are asbestos products and bad drugs.  The asbestos products have been found to cause mesothelioma and several forms of cancer and other asbestos diseases, while dangerous drugs have been linked to death, serious heart problems, drug interactions, and suicide.  Other dangerous products that have been linked to serious disease include silica, chemical pollutants, lead, radon, EMFs, welding rodstoxic mold infestations and other environmental toxins have caused death and serious harm to millions.  In the work environment alone undisclosed and known toxins including asbestos, silica, and welding rods have caused occupational diseases and fatalities including mesothelioma, numerous forms of cancer, and Parkinson's disease.

This web site was created by Texas Toxic Tort Lawyer Jason Coomer and is intended only as general information on some of the most dangerous products and toxic products that have been sold by drug manufacturers, medical device manufacturers, and asbestos manufacturers, or are in use by large companies attempting to profit and make money from the sale of dangerous products that can cause serious toxic exposures.  For more information on a dangerous product or toxic exposure follow the links found above, e-mail  an inquiry to info@toxicexposurelaw.com, or submit an inquiry.

This website provides basic information on some well established toxins and some potential toxins that are best to avoid.  Overall, ToxicDoseLaw.com and ToxicExposureLaw.com recommend using the precautionary principle by minimizing exposure to potential toxins until they can be proven nontoxic.

For more information on the ToxicDoseLaw.com or ToxicExposureLaw.com information center, follow the links on this website, submit an inquiry, email us at info@toxicexposurelaw.com or call us at (512) 474-5577.

  Submit an inquiry

*
*
*

* denotes a required field.

 
| Home | Asbestos | Bad Drugs | Lead Paint | Silica  | Mercury | Toxic Mold |

Jurisdiction for the ToxicDoseLaw.com and ToxicExposureLaw.com Web Presence is in Austin, Travis County, Texas.
AbogadosdeTejas.com, LLC, Copyright 1999-20010